Modern methods for compliance and quality engineering in life sciences
Agile software development and strong compliance don’t have to be a contradiction. Modern QA using CSA and GAMP 5 (2nd Edition) ensures both patient safety and innovation.
Many life sciences companies still rely on classical CSV approaches but these hinder innovation, complicate audits and are no longer suited to today’s development models.
Late-stage testing, overdocumentation and rigid validation models—traditional CSV has become a bottleneck for many life sciences organizations.
In an environment shaped by increasing regulatory pressure and the demand for faster innovation, new, more flexible approaches are needed.
A risk-based model like computerized system assurance (CSA) helps modernize quality assurance—without compromising regulatory compliance.
CSA enables leaner validation processes, leverages automation where it matters most and integrates seamlessly with frameworks like GAMP 5 (2nd Edition). The result: solutions that enhance audit-readiness, efficiency and innovation simultaneously.
Life sciences and pharma: Towards efficient, agile and highly automated quality assurance
When quality assurance and testing only take place at the end of development, the risks are high. It’s more effective to embed both into every phase—agile, automated and aligned with today’s regulatory standards. But making that shift requires both deep domain expertise and modern IT development know-how.
Our new ebook outlines the challenges and proven strategies for modernizing QA and how Cognizant helps large and mid-sized life sciences organizations make it happen.
Examples of successful quality engineering transformations
Whether a global player or a locally focused mid-sized company, Cognizant expertly supports the transition to agile, highly automated testing methodologies.
Comprehensive life sciences expertise for every requirement
Cognizant offers a broad portfolio tailored to both mid-sized and global life sciences companies. We provide a mature tool set, significant annual investments in R&D and a global network of life sciences experts capable of implementing fully automated testing and validation platforms.
